Horizon Kinetics’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$357K Hold
15,480
0.01% 281
2018
Q3
$365K Hold
15,480
0.01% 404
2018
Q2
$357K Hold
15,480
0.01% 405
2018
Q1
$381K Hold
15,480
0.01% 393
2017
Q4
$415K Hold
15,480
0.01% 329
2017
Q3
$373K Hold
15,480
0.01% 410
2017
Q2
$332K Hold
15,480
0.01% 431
2017
Q1
$265K Sell
15,480
-94
-0.6% -$1.64K 0.01% 451
2016
Q4
$279K Hold
15,574
0.01% 446
2016
Q3
$324K Buy
15,574
+94
+0.6% +$2.33K 0.01% 444
2016
Q2
$416K Sell
15,480
-94
-0.6% -$2.58K 0.01% 411
2016
Q1
$422K Sell
15,574
-80
-0.5% -$2.14K 0.01% 429
2015
Q4
$455K Hold
15,654
0.01% 406
2015
Q3
$425K Buy
15,654
+174
+1% +$4.93K 0.01% 402
2015
Q2
$424K Hold
15,480
0.01% 421
2015
Q1
$413K Sell
15,480
-334
-2% -$7.69K 0.01% 426
2014
Q4
$335K Buy
15,814
+334
+2% +$7.46K ﹤0.01% 448
2014
Q3
$369K Hold
15,480
﹤0.01% 433
2014
Q2
$358K Hold
15,480
﹤0.01% 449
2014
Q1
$353K Sell
15,480
-61,920
-80% -$1.32M ﹤0.01% 447
2013
Q4
$286K Buy
77,400
+61,920
+400% +$1.08M ﹤0.01% 470
2013
Q3
$262K Hold
15,480
﹤0.01% 475
2013
Q2
$240K Buy
+15,480
New +$258K ﹤0.01% 394

Other funds holding NVO

Horizon Kinetics's NVO Position: Q4 2018 in Review

Horizon Kinetics held its Novo Nordisk (NVO) position steady in Q4 2018 at 15,480 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #281.

Horizon Kinetics first reported a position in NVO in Q2 2013 and has held it in 23 quarters since. The position peaked at $455K in Q4 2015. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Horizon Kinetics held 15,480 shares of Novo Nordisk worth $357K as of Q4 2018.
  • Horizon Kinetics left its Novo Nordisk share count unchanged in Q4 2018.
  • Novo Nordisk made up 0.01% of Horizon Kinetics's portfolio in Q4 2018, its #281 holding.
  • Horizon Kinetics first reported a position in Novo Nordisk in Q2 2013 and has held it in 23 quarters since.
  • Horizon Kinetics's Novo Nordisk position peaked at $455K in Q4 2015.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.